MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients

DSpace Repository

MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade : Results of a retrospective multicentre analysis of 364 patients

Author: Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie
Tübinger Autor(en):
Eigentler, Thomas Kurt
Published in: European Journal of Cancer (2018), Bd. 98, S. 10-16
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2018.04.010
ISSN: 1879-0852
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)